New Molecular and Organelle Alterations Linked to Down Syndrome Heart Disease
Open Access
- 18 January 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 12, 792231
Abstract
Down syndrome (DS) is a genetic disorder caused by a trisomy of the human chromosome 21 (Hsa21). Overexpression of Hsa21 genes that encode proteins and non-coding RNAs (ncRNAs) can disrupt several cellular functions and biological processes, especially in the heart. Congenital heart defects (CHDs) are present in 45–50% of individuals with DS. Here, we describe the genetic background of this condition (Hsa21 and non-Hsa21 genes), including the role of ncRNAs, and the relevance of these new players in the study of the pathophysiology of DS heart diseases. Additionally, we discuss several distinct pathways in cardiomyocytes which help maintain a functional heart, but that might trigger hypertrophy and oxidative stress when altered. Moreover, we highlight the importance of investigating how mitochondrial and lysosomal dysfunction could eventually contribute to understanding impaired heart function and development in subjects with the Hsa21 trisomy. Altogether, this review focuses on the newest insights about the gene expression, molecular pathways, and organelle alterations involved in the cardiac phenotype of DS.Keywords
Funding Information
- Fondo Nacional de Desarrollo Científico y Tecnológico
- Fondo de Financiamiento de Centros de Investigación en Áreas Prioritarias
- Universidad de Chile
- International Center for Genetic Engineering and Biotechnology
This publication has 115 references indexed in Scilit:
- Genetic Modifiers Predisposing to Congenital Heart Disease in the Sensitized Down Syndrome PopulationCirculation: Cardiovascular Genetics, 2012
- miRNA-155 upregulation and complement factor H deficits in Down’s syndromeNeuroReport, 2012
- Over-Expression of DSCAM and COL6A2 Cooperatively Generates Congenital Heart DefectsPLOS Genetics, 2011
- Deficit of complex I activity in human skin fibroblasts with chromosome 21 trisomy and overproduction of reactive oxygen species by mitochondria: involvement of the cAMP/PKA signalling pathwayBiochemical Journal, 2011
- ALK2 mutation in a patient with Down's syndrome and a congenital heart defectEuropean Journal of Human Genetics, 2011
- Mitochondrial morphology and cardiovascular diseaseCardiovascular Research, 2010
- Epigenetic principles and mechanisms underlying nervous system functions in health and diseaseProgress in Neurobiology, 2008
- Maternal age and risk for trisomy 21 assessed by the origin of chromosome nondisjunction: a report from the Atlanta and National Down Syndrome ProjectsHuman Genetics, 2008
- Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomyBMC Genomics, 2007
- Clusters of Internally Primed Transcripts Reveal Novel Long Noncoding RNAsPLOS Genetics, 2006